Skip to main content
. 2024 Jan 24;15:1288362. doi: 10.3389/fphar.2024.1288362

FIGURE 4.

FIGURE 4

Evaluation of intracranial haemorrhage events. (A–D) The cumulative curve visualizes the interval between the initiation of HER2 inhibitors and the occurrence of intracranial haemorrhage. (E) Percentage of patients treated with four HER2 monotherapies who developed intracranial haemorrhage who had concomitant thrombocytopenia.